DEREK MEAD: Open Payments
NPI 1194450528 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 11 payments from 9 companies in 2025. Trend: 2023 $380 · 2024 $1,649 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $94 |
| Medtronic, Inc. | 2 | $69 |
| Amgen Inc. | 2 | $30 |
| Novo Nordisk Inc | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Chiesi USA, Inc. | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Edwards Lifesciences Corporation | 1 | $17 |
| ENDOTRONIX, INC. | 1 | $14 |
Products named: LifeVest, RESOLUTE ONYX, REPATHA, Wegovy, LEQVIO, ABRE, KENGREAL, ONPATTRO.
Industry payments across KS — which companies pay providers there.
